000			02111 a2200529 4500
005			20250513142826.0
264		0	_c19980812
008			199808s 0 0 eng d
022			_a0927-3042
024	7		_a10.1007/978-1-4615-6189-7_12 _2doi
040			_aNLM _beng _cNLM
100	1		_aCobleigh, M A
245	0	0	_aHormone replacement therapy and nonhormonal control of menopausal symptoms in breast cancer survivors. _h[electronic resource]
260			_bCancer treatment and research _c1998
300			_a209-30 p. _bdigital
500			_aPublication Type: Journal Article; Review
650	0	4	_aAntineoplastic Agents, Hormonal _xadverse effects
650	0	4	_aBreast Neoplasms _xchemically induced
650	0	4	_aCardiovascular Diseases _xprevention & control
650	0	4	_aChemotherapy, Adjuvant _xadverse effects
650	0	4	_aClinical Trials as Topic
650	0	4	_aContraindications
650	0	4	_aDrug Interactions
650	0	4	_aDyspareunia _xprevention & control
650	0	4	_aEndometrial Neoplasms _xchemically induced
650	0	4	_aEstrogen Antagonists _xadverse effects
650	0	4	_aEstrogen Replacement Therapy _xadverse effects
650	0	4	_aEstrogens _xadverse effects
650	0	4	_aFemale
650	0	4	_aFlushing _xprevention & control
650	0	4	_aHumans
650	0	4	_aMenopause
650	0	4	_aMiddle Aged
650	0	4	_aMood Disorders _xprevention & control
650	0	4	_aNeoplasm Metastasis
650	0	4	_aNeoplasm Recurrence, Local _xchemically induced
650	0	4	_aNeoplasms, Hormone-Dependent _xchemically induced
650	0	4	_aNeoplasms, Second Primary _xchemically induced
650	0	4	_aNeoplastic Stem Cells _xdrug effects
650	0	4	_aOsteoporosis _xprevention & control
650	0	4	_aPrimary Ovarian Insufficiency _xprevention & control
650	0	4	_aSleep Wake Disorders _xprevention & control
650	0	4	_aTamoxifen _xadverse effects
650	0	4	_aVaginitis _xprevention & control
773	0		_tCancer treatment and research _gvol. 94 _gp. 209-30
856	4	0	_uhttps://doi.org/10.1007/978-1-4615-6189-7_12 _zAvailable from publisher's website
999			_c9554489 _d9554489